ABSTRACT A 67-year-old Chinese woman with comorbidities of chronic obstructive lung disease, hypertension and prior coronary artery bypass surgery presented with severe functional mitral regurgitation (MR) and severely depressed left ventricular function. She was in New York Heart Association (NYHA) Class II-III. Due to high surgical risk, she was referred for percutaneous treatment with the MitraClip valve repair system. This procedure is typically performed via the femoral venous system and involves a transseptal puncture. A clip is delivered to grasp the regurgitant mitral valve leaflets and reduce MR. This was performed uneventfully in our patient, with reduction of MR from 4+ to 1+. She was discharged on post-procedure Day 2 and her NYHA class improved to Class I. This was the first successful MitraClip procedure performed in Asia and represents a valuable treatment option in patients with severe MR, especially those with functional MR or those at high surgical risk.
INTRODUCTION
MitraClip is a catheter-based device designed to perform edge-to-edge reconstruction of an insufficient mitral valve while the heart is beating, as an alternative to the conventional surgical approach. (1) (2) (3) The procedure is performed in a to the MitraClip showed that the device was less efficacious than surgery but was superior in safety. (4) Both groups had similar improvements in left ventricular size, New York Heart Association (NYHA) functional class and quality of life. We describe here the first MitraClip procedure performed in Asia.
CASE REPORT
A 67-year-old Chinese woman with a history of congestive heart failure, coronary artery disease, chronic obstructive lung 
DISCUS SION
MitraClip is the first-in-class percutaneous therapy for mitral regurgitation (Fig. 4) . It is a transcatheter technology based on the surgical techniques pioneered by Alfieri et al and emulates the surgical double-orifice approach to MR repair. 
